HCPCS Level IIdrugActive
J1596
Inj, glycopyrrolate, 0.1 mg
BETOS: O1E
Effective: 2025-01-01
Description
Injection, glycopyrrolate, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Glycopyrrolate Injection
Manufacturer
FreseniUS Kabi USA, LLC
HCPCS Dosage
0.1 MG
Billing Units
10.0000
84
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.